NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 8, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and

Related Keywords

Chad ,Switzerland ,Swiss ,Alex Zwyer ,Keith Harrison Dewedoff ,Marianne Lambertson ,Kaizen Bioscience ,Kellogg College ,Pharmaceutics Ltd ,Northeastern University ,Nasdaq ,Ceptur Therapeutics Inc ,Villanova University ,Drug Administration ,Code Biotherapeutics Inc ,Advisor For Danforth Advisors ,Investments Wealth Institute ,European Medicines Agency ,Exchange Commission ,Interim Chief Financial Officer ,Danforth Advisors ,Ceptur Therapeutics ,Graduate Diploma ,Portfolio Management ,Chief Executive Officer ,Chad Hellmann ,Idiopathic Hypersomnia ,Orphan Disease Designation ,Mazindol Controlled Release ,Hyperactivity Disorder ,Gefallene Big Techs ,Pharmaceutics ,Ppoints ,Keith ,Arrison ,Ewedoff ,Interim ,Chief ,Financial ,Officer ,